The healthcare sector is transforming with the adoption of digital technologies, improved productivity, and increasing R&D ...
FemPulse’s CEO Alexandra Haessler said the FemPulse Ring was designed as an “internal wearable” with a “set it and forget it” ...
FemPulse announced today that it received FDA investigational device exemption (IDE) approval for its overactive bladder (OAB ...
EndoQuest Robotics announced today that it received FDA investigational device exemption (IDE) for a study of its surgical ...
RapidPulse, Inc. announced FDA approval of an investigational device exemption (IDE) for the company to study the RapidPulse c ...
From a company layoff to FDA nods, here are five key developments from spine and orthopedic medtech companies since Dec. 4.
EndoQuest will commence its PARADIGM clinical trial for endoluminal robotic colorectal surgery at five leading US hospitals ...
Theradaptive earned the FDA's investigational device exemption approval to broaden its clinical research for the OsteoAdapt SP implant, the company said Dec. 10 ...
In a multicenter, prospective, nonrandomized study evaluating outcomes of fenestrated-branched endovascular aortic repair (FB ...
NeuroPace (NPCE) announced completion of enrollment and implant procedures in its feasibility investigational device exemption, or IDE, study ...
In the CONDUCT-TAVI study, the use of a self-expanding valve was not associated with an increased risk of pacemaker.
Find earnings, economic, stock splits and IPO calendars to track upcoming financial events from Yahoo Finance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback